Back
NovaBay Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
NBY
NovaBay Pharmaceuticals
Last Price:
$0.59
Seasonality Move:
-8.66%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NovaBay Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.59 | Sell |
| 20-day SMA: | 0.56 | Buy |
| 50-day SMA: | 0.6 | Sell |
| 200-day SMA: | 0.71 | Sell |
| 8-day EMA: | 0.58 | Buy |
| 20-day EMA: | 0.57 | Buy |
| 50-day EMA: | 0.59 | Sell |
| 200-day EMA: | 2.4 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 51.91 | Buy |
| Chaikin Money Flow: | 2976 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.53 - 0.61) | Buy |
| Bollinger Bands (100): | (0.55 - 0.67) | Sell |
NovaBay Pharmaceuticals Technical Analysis
| Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.59 while NBY 8-day simple moving average is 0.59, which is a Sell signal.
-
The stock price of NBY is 0.59 while NovaBay Pharmaceuticals 20-day SMA is 0.56, which makes it a Buy.
-
NovaBay Pharmaceuticals 50-day simple moving average is 0.60 while NBY share price is 0.59, making it a Sell technically.
-
NBY stock price is 0.59 and NovaBay Pharmaceuticals 200-day simple moving average is 0.71, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
26
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a SellThe current NovaBay Pharmaceuticals [NBY] share price is $0.59. The Score for NBY is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
3.4M
Price in USD:
0.59
Share Volume:
6K
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
9.08
52-Week Low:
0.36
Sell
26
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?The NovaBay Pharmaceuticals stock price is 0.59 USD today.
-
Will NBY stock go up or go down?NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is NovaBay Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.59 while NBY 8-day exponential moving average is 0.58, which is a Buy signal.
-
The stock price of NBY is 0.59 while NovaBay Pharmaceuticals 20-day EMA is 0.57, which makes it a Buy.
-
NovaBay Pharmaceuticals 50-day exponential moving average is 0.59 while NBY share price is 0.59, making it a Sell technically.
-
NBY stock price is 0.59 and NovaBay Pharmaceuticals 200-day simple moving average is 2.40, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
-
NBY Moving Average Covergence Divergence (MACD) indicator is -0, suggesting NovaBay Pharmaceuticals is a Sell
-
NovaBay Pharmaceuticals Relative Strength Index (RSI) is 51.91, which suggest NovaBay Pharmaceuticals is overbought
-
The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.53 - 0.61), which suggest NovaBay Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.55 - 0.67), which suggest NovaBay Pharmaceuticals is a Sell
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.